35.30Open35.30Pre Close0 Volume1 Open Interest37.50Strike Price0.00Turnover151.85%IV-4.06%PremiumDec 20, 2024Expiry Date38.38Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9812Delta0.0016Gamma1.96Leverage Ratio-0.0329Theta0.0217Rho1.92Eff Leverage0.0086Vega
Insmed Stock Discussion
$MicroStrategy (MSTR.US)$
— Known for its heavy investment in Bitcoin, MicroStrategy has seen significant price fluctuations but managed to outperform Nvidia’s annual performance.
Sector: Technology
Industry: Software – Application
Market Cap: $26.07B
Price: $1,469.43
1YR Perf: 400.85%
YTD Perf: 132.64%
Carvana Co.
$Carvana (CVNA.US)$
— Carvana’s innovative online car sales platform has driven strong performanc...
Just after the close at 4 PM EST, the $S&P 500 Index traded up 0.03%, the $Dow Jones Industrial Average fell about 0.655%, and the $Nasdaq Composite Index closed up 0.59...
Gapping up
$NVIDIA (NVDA.US)$ stock rose 2.7%, with the tech giant's stock continuing to gain, with its market value surpassing $2.5 trillion since its quarterly results, solidifying its position as the third most valuable company on Wall Street.
$Apple (AAPL.US)$ stock rose 1.9% after the iPhone maker's smartphone shipments in China were 52% higher in April than a year ago, according to data from a research firm ...
Benzinga· 2 mins ago
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Liquidia (LQDA.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$MorphoSys (MOR.US)$ Phase 3
$Immunocore (IMCR.US)$ Phase 3
$Crinetics (CRNX.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$Capricor Therapeutics (CAPR.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3 ...
No comment yet